State Street Health Care Select Sector SPDR ETF
XLVETFISIN US81369Y2090, Provider: SPDR
How the score and crash risk are calculated
The ETF's score is the score of its holdings, weighted by their share.
Crash risk counts how often the ETF fell by 30% or more within 12 months over the last ten years, with distributions reinvested. If its history is shorter, the longest history of an ETF on the same index counts, or failing that, the same fund on another exchange in the same currency.
Price and trend
Price history
+24% in one yearThe chart shows daily closes over 10 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Above the 200-day line: the price is 18% above it.
Since July 2026 the 50-day line has been above the 200-day line; the trend has turned up.
Overheated: the price has risen very quickly lately (RSI 70).
The price is at its 52-week high. Largest decline in 10 years: 29% (January 2020 to March 2020).
Chart figures for advanced users
- SMA 50$175.05
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$160.20
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)70
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$142.84
- The lowest closing price of the last twelve months.
- Resistance$189.66
- The highest closing price of the last twelve months.
Return and risk
Return by calendar year
From the last close of the prior year to the last close of the year, with distributions reinvested.
The ten largest holdings
| Holding | Weight | Score |
|---|---|---|
| Eli Lilly and CompanyLLY | 16.77% | 85 |
| Johnson & JohnsonJNJ | 10.05% | 75 |
| AbbVie Inc.ABBV | 7.65% | 74 |
| UnitedHealth Group IncorporatedUNH | 5.35% | 67 |
| Merck & Co., Inc.MRK | 5.33% | 68 |
| Thermo Fisher Scientific Inc.TMO | 3.80% | 67 |
| Amgen Inc.AMGN | 3.71% | 76 |
| Gilead Sciences, Inc.GILD | 3.06% | 69 |
| Abbott LaboratoriesABT | 2.73% | 62 |
| Pfizer Inc.PFE | 2.42% | 60 |
The ETF's score is the score of its holdings, weighted by their share.
Countries
- United States100.0%
Sectors
- Healthcare100.0%
Valuation of holdings
From 100% of the fund with data, weighted by share.
Distributions
By year
- 2020$1.69 (1.49%)
- 2021$1.87 (1.33%)
- 2022$1.99 (1.47%)
- 2023$2.17 (1.59%)
- 2024$2.29 (1.67%)
- 2025$2.48 (1.60%)
- 2026 so far$1.89 (1.00%)
Latest payments
| Ex-date | Amount per share |
|---|---|
| 21 Sept 2026 | $0.64 |
| 22 Jun 2026 | $0.66 |
| 23 Mar 2026 | $0.59 |
| 22 Dec 2025 | $0.66 |
| 22 Sept 2025 | $0.62 |
| 23 Jun 2025 | $0.63 |
| 24 Mar 2025 | $0.56 |
| 23 Dec 2024 | $0.62 |
About this ETF
The State Street Health Care Select Sector SPDR ETF tracks the Healthcare Select Sector. It buys the index securities itself (physical). It pays out its income. It costs 0.08% a year. Fund assets are $50.57B. It was launched in December 1998.
Run a savings plan and lump sum with real pricesReturns with distributions reinvested, in the trading currency; the price chart shows the traded price. Master data and holdings from FMP. Not investment advice.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- US closing prices, holdings, costs and holding scores from the nightly run
- The score is the average of the holdings' scores, weighted by their share, across the rated holdings. An estimate from a published model, not a fact and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.